Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in ...

VTAMA was the only steroid-free topical AAD found supported by high certainty of evidence across all severities in children 2 years and older with AD.

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

Higher maternal prepregnancy body mass index and birth length were associated with greater risk for atopic dermatitis by age 3 years.

The American Academy of Dermatology (AAD) released 2 guidelines for the prevention of pediatric atopic dermatitis.

In this video, Aaron Mark Drucker, MD, ScM, FRCPC, discusses his talk on the relative efficacy of small molecule, oral JAK ...

A topic dermatitis is a chronic condition that tends to rear its itchy head during certain periods before subsiding — for months, possibly, or even years. It particularly affects the insides of the ...

This episode focuses on long-acting interleukin (IL)-13 biologics and what less frequent dosing could mean for efficacy, ...

After receiving dupilumab vs. topical corticosteroid or prednisone for up to 24 months, the risk for alopecia areata ...

Credit: Getty Images. Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of ...

Private placement led by Coastlands Capital with participation from additional new and existing investors Proceeds will support further ...